IRIS - Res&Arch Institutional Research Information System - Research & Archive

Ingrosso, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.503
AS - Asia 2.358
EU - Europa 1.493
SA - Sud America 416
AF - Africa 56
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.434
SG - Singapore 1.305
IE - Irlanda 354
HK - Hong Kong 340
BR - Brasile 330
IT - Italia 306
RU - Federazione Russa 292
CN - Cina 290
FR - Francia 147
VN - Vietnam 132
DE - Germania 105
GB - Regno Unito 59
KR - Corea 48
BD - Bangladesh 43
FI - Finlandia 35
AR - Argentina 34
UA - Ucraina 32
CA - Canada 31
IN - India 30
PL - Polonia 29
NL - Olanda 24
AT - Austria 23
MX - Messico 23
JP - Giappone 21
TR - Turchia 20
SE - Svezia 19
IQ - Iraq 15
CH - Svizzera 14
ZA - Sudafrica 14
PK - Pakistan 13
UZ - Uzbekistan 13
CO - Colombia 12
ID - Indonesia 12
EC - Ecuador 10
ES - Italia 10
PH - Filippine 10
CZ - Repubblica Ceca 9
MA - Marocco 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
SA - Arabia Saudita 7
BE - Belgio 6
IL - Israele 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
GR - Grecia 4
JM - Giamaica 4
NP - Nepal 4
PS - Palestinian Territory 4
UY - Uruguay 4
BG - Bulgaria 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
IR - Iran 3
LB - Libano 3
AM - Armenia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NE - Niger 1
NO - Norvegia 1
Totale 6.824
Salva come PNG Salva come JPEG
Città #
Singapore 958
Dublin 352
Hong Kong 340
San Jose 284
Chandler 255
Ashburn 171
Boardman 160
Santa Clara 123
Altamura 120
San Mateo 119
Lauterbourg 86
Moscow 83
Lawrence 73
Medford 73
Princeton 73
The Dalles 69
Beijing 64
Seoul 47
Los Angeles 45
Munich 42
Ho Chi Minh City 37
New York 36
Andover 33
São Paulo 33
Perugia 29
Wilmington 28
Hanoi 24
Houston 24
Frankfurt am Main 23
Warsaw 20
Ann Arbor 19
Tokyo 19
Des Moines 18
Piscataway 18
Dallas 17
Nuremberg 17
Saint Petersburg 17
Turku 17
Redmond 16
Atlanta 15
Rome 15
Brooklyn 14
Norwalk 14
Milan 12
Amsterdam 11
Boston 11
Dong Ket 11
Helsinki 11
Johannesburg 11
Montreal 11
Orem 11
Paris 11
Phoenix 11
Stockholm 11
Brasília 10
Chennai 10
Chicago 10
Falls Church 10
Poplar 10
Toronto 10
Council Bluffs 9
San Paolo di Civitate 9
Baghdad 8
Menlo Park 8
Mexico City 8
Porto Alegre 8
Redwood City 8
Rio de Janeiro 8
San Francisco 8
Terni 8
Vienna 8
Buffalo 7
Denver 7
Guangzhou 7
Haiphong 7
Hefei 7
London 7
Tashkent 7
Ankara 6
Belo Horizonte 6
Columbus 6
Curitiba 6
Goiânia 6
Lausanne 6
Lima 6
Prato 6
Amman 5
Baku 5
Bologna 5
Brussels 5
Da Nang 5
Dhaka 5
Florence 5
Istanbul 5
Jeddah 5
Karachi 5
Kuala Lumpur 5
Lappeenranta 5
Quito 5
Salvador 5
Totale 4.479
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 162
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 137
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients 105
Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer 104
Acute and late toxicity after three-dimensional conformal image-guided radiotherapy for localized prostate cancer 100
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 100
Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial 97
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 97
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 97
Breakdown of symbiosis in radiation-induced oral mucositis 97
Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction 96
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer 96
Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications 95
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer 95
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 94
Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes 93
Stereotactic radiotherapy for brain metastases: Imaging tools and dosimetric predictive factors for radionecrosis 93
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience 92
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 89
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 88
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 87
Prostate Cancer Recurrence in Kidney Transplant Recipient 15 Years After Radical Prostatectomy: A Case Report. 87
Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy 85
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective 85
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 84
Current therapeutic options in metastatic castration-resistant prostate cancer 83
Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions 82
Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. 81
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 80
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 80
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 78
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 77
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 76
Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study 76
Stereotactic radiotherapy for liver oligometastases 76
Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis 76
Predicting genitourinary toxicity in three-dimensional conformal radiotherapy for localized prostate cancer: A dose-volume parameters analysis of the bladder 75
Evaluation of serrated intraprostatic gold coils positional stability using on-board cone beam computed tomography scans acquired throughout the radiation treatment course 74
Guidelines on prostate carcinoma - AIRO, 2016 73
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 73
Stereotactic radiotherapy for brain oligometastases 72
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 71
Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases 70
Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases 70
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 70
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 69
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 69
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 67
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 67
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study 66
High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool? 66
Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis 66
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 66
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus 65
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 65
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope? 65
Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: Three longitudinal case studies 65
Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer 65
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 65
Choline PET/CT in recurrent prostate cancer 64
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review 62
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer 61
Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients 60
Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer 60
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 60
Stereotactic radiotherapy for lung oligometastases 60
Re: PSMA-Guided Metastases Directed Therapy for Bone Castration Sensitive Oligometastatic Prostate Cancer: A Multi-Institutional Study 59
Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis 59
Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience 59
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 59
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities 57
Image-guided-radiotherapy retreatment of spine metastasis: A case report and radiobiological evaluation 57
Volumetric image-guided conformal radiotherapy for localized prostate cancer: Analysis of dosimetric and clinical factors affecting acute and late toxicity 56
Intra-parotid facial nerve schwannoma with intra-temporal extension; A case report. Is there a role for stereotactic radiotherapy? 56
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives 56
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 55
Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach: SBRT in oligometastatic elderly patients 55
Oligometastatic prostate cancer: The game is afoot 55
The time factor in oncology: Consequences on tumour volume and therapeutic planning 55
Stereotactic radiotherapy for bone oligometastases 54
Acute and late toxicities after moderate hypo-fractionated radiation therapy to the chest wall/breast and regional lymph nodes: a retrospective observational study 53
High-dose-rate brachytherapy with surface applicator in penile cancer 53
The role of adjuvant radiother apy in the treatment of papillary tumors of the pineal region: Some general considerations and a case report 52
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 50
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 49
Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator (TM) micro-MLC: A dosimetric analysis 49
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis 49
The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation 49
Retro-orbital granulocytic sarcoma: Case report 48
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 47
The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer 46
Radiotherapy in the era of COVID-19 45
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature 40
Stereotactic radiotherapy for oligometastases in the lymph nodes 40
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 40
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 38
Editorial: Reviews in genitourinary oncology 35
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 17
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 15
Totale 7.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022464 1 52 0 6 4 5 2 152 11 33 48 150
2022/20231.118 77 264 14 50 64 97 10 60 432 3 40 7
2023/2024519 25 48 24 15 6 0 141 6 34 14 97 109
2024/20251.490 23 120 45 40 229 62 45 106 380 94 244 102
2025/20263.124 224 220 170 326 428 301 629 214 271 228 82 31
Totale 7.045